Enfortumab Vedotin and Pembrolizumab doubled survival rates, with fewer serious side effects in advanced bladder cancer.
pull down to refresh
pull down to refresh
Enfortumab Vedotin and Pembrolizumab doubled survival rates, with fewer serious side effects in advanced bladder cancer.
Cool, but what is it?
a drug consisting of 2 parts
Imagine if we actually eliminated the reasons people get it at all